Cart
sales@molnova.com
IUN76750
CAS No. 1690176-75-0
IUN76750( PAR-2-IN-1 )
Catalog No. M23759 CAS No. 1690176-75-0
IUN76750 is a PAR- 2 signaling pathway inhibitor with anti-inflammatory and anticancer effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 164 | In Stock |
|
| 50MG | 250 | In Stock |
|
| 100MG | 367 | In Stock |
|
| 200MG | 518 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIUN76750
-
NoteResearch use only, not for human use.
-
Brief DescriptionIUN76750 is a PAR- 2 signaling pathway inhibitor with anti-inflammatory and anticancer effects.
-
DescriptionIUN76750 is a PAR- 2 signaling pathway inhibitor with anti-inflammatory and anticancer effects.
-
In Vitro——
-
In Vivo——
-
SynonymsPAR-2-IN-1
-
PathwayGPCR/G Protein
-
TargetPAR
-
RecptorPAR-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1690176-75-0
-
Formula Weight267.71
-
Molecular FormulaC12H14ClN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:83.33 mg/mL?(311.27 mM;?Need ultrasonic)
-
SMILESCC(C)(C)C1=CC(=NN2C1=NC(=C2)C(=O)OC)Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Luc J. Farmer, et al. Imidazopyridazines useful as inhibitors of the par-2 signaling pathway. WO2015048245A1.
molnova catalog
related products
-
TRAP-6(2TFA)
TRAP-6(2TFA) is an agonist of protease-activated receptor 1 (PAR1).
-
Parstatin (human)
Cell-permeable peptide cleaved from protease-activated receptor 1 (PAR1) upon receptor activation. Attenuates endothelial cell migration and proliferation (IC50 ~ 3 μM), and induces cell cycle arrest. Promotes activation of caspase-3 and exhibits pro-apoptotic activity in vitro. Inhibits angiogenesis and exhibits cardioprotective activity in vivo.
-
BMS-986120
BMS-986120 (BMS986120)?is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4.
